Healthcare expenditure and technology use in pediatric diabetes care

BMC Endocrine Disorders

Table 1 Baseline characteristics of the study population (n = 5,474)

		N	%
Sex
	Male	2,848	52.0
	Female	2,626	48.0
Age (years)		12.3 ± 3.7
Age group (years)
	0	6	0.1
	1–5	336	6.1
	6–10	1,119	20.4
	11–15	2,528	46.2
	16–17	1,485	27.1
SES
	Low	1,811	33.1
	Intermediate	1,735	31.7
	High	1,908	34.9
	Unknown	20	0.4
Mortality		1
Hospital of treatment	Secondary	5,279	96.4
Hospital of treatment	Tertiary	195	3.6
Treating medical specialty*
	Pediatrics	5,202	95.0
	Internal medicine	60	1.1
	Pediatrics & Internal medicine	5	0.1
	Surgery	9	0.2
	Ophthalmology	1,093	20.0
	Ophthalmology & Pediatrics	873	15.9
Diabetes-related consultations^*
Pediatrics	Number of consultations	7 [0—45]
	1—3	493	9.0
	4—6	1,935	35.3
	7—9	2,118	38.7
	10—12	426	7.8
	≥ 13	213	3.9
Ophthalmology	Number of consultations	1 [1–34]
	1	817	14.9
	2	235	4.3
	≥ 3	41	0.7
Surgery	Number of consultations	1 [0—11]
Internal medicine	Number of consultations	2.5 [0–18]
All-cause hospitalisations
Patients with hospitalisations		1,008	18.4
	1	820	15.0
	2	133	2.4
	≥ 3	57	1.0
Diabetes technology
Insulin pump care activities		3,063	56.0
	Number of care activities	7 [1—180]
rtCGM care activities		1,608	29.4
	Number of care activities	5 [1—173]
Insulin pump & rtCGM care activities		1,492	27.3

Numbers are presented as mean ± SD, median [range] or number of patients with percentage (%). All consultations, activities, and hospitalisations are expressed per year
SES Socio-economic status, rtCGM real-time Continuous Glucose Monitoring
^* Determined by a diabetes-related diagnosis treatment combination code (DBC)

ISSN: 1472-6823